Children with HIV on dolutegravir (Tivicay)-based antiretroviral therapy (ART) can safely receive the standard prophylactic ...

Introduction Integration of management of tuberculosis (TB) and HIV with prevention and treatment of non-communicable ...

Untreated human immunodeficiency virus (HIV) infection markedly increases the risk of tuberculosis, which remains the most common cause of hospitalization and death globally among people with HIV ...

Sepsis is a leading global cause of hospital deaths, occurring when the body's response to infection damages tissue and causes organs to fail. Africa bears the world's highest burden of sepsis, with ...

Major trial finds immediate or high-dose TB treatment does not lower overall mortality in HIV-related sepsis, except in ...

Tuberculosis (TB) remains the leading cause of death among people living with HIV. Although HIV-1 and Mycobacterium tuberculosis (Mtb) coinfection remains a major public health concern, this problem ...

Existing treatments control TB and HIV, but the immune system does not revert to normal, helping explain why people living with HIV remain susceptible to infections and underscoring the need for ...

Tuberculosis (TB), HIV, and cancer are three of the most significant health challenges affecting Uganda today. Each disease presents a heavy burden on its own, but their interaction makes prevention, ...

The Xpert MTB/Ultra molecular diagnostic test for stool samples, until now recommended only for children, could be established as an additional test for diagnosing tuberculosis in adults living with ...

Sepsis is a leading global cause of hospital deaths, occurring when the body's response to infection damages tissue and causes organs to fail. Africa bears the world's highest burden of sepsis, with ...

In his State of the Nation Address (SONA) this week, President Cyril Ramaphosa announced that the country will begin distributing Lenacapavir, a proven injection to prevent HIV transmission.